tiprankstipranks
Advertisement
Advertisement

Medley Posts Strong Revenue Growth but Quarterly Loss, Reaffirms Robust 2026 Outlook

Story Highlights
  • Medley grew quarterly sales and EBITDA strongly but recorded a small operating and net loss.
  • The company kept its no-dividend stance while reaffirming bullish 2026 earnings guidance and growth plans.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Medley Posts Strong Revenue Growth but Quarterly Loss, Reaffirms Robust 2026 Outlook

Meet Samuel – Your Personal Investing Prophet

Medley ( (JP:4480) ) has issued an update.

Medley reported consolidated net sales of ¥10.19 billion for the quarter ended March 31, 2026, up 25.2% year on year, with EBITDA rising 48.1% to ¥631 million but a slight operating loss of ¥67 million and a net loss attributable to owners of the parent of ¥62 million. Total assets increased to ¥43.68 billion while the equity ratio declined to 29.9% amid higher treasury share holdings, and the company maintained a no-dividend policy but reaffirmed its full-year 2026 forecast, projecting 26.1% net sales growth and an 84.5% jump in profit attributable to owners of the parent to ¥1.8 billion, signaling confidence in its growth trajectory despite near-term losses.

For full-year 2026, Medley expects EBITDA of ¥5.8 billion, operating profit of ¥2.95 billion, and ordinary profit of ¥3.25 billion, underscoring its view that current investments will translate into stronger profitability. The unchanged guidance suggests that management sees no material deterioration in business conditions and aims to solidify its position in the digital healthcare market, although the lower equity ratio and continued absence of dividends highlight a focus on reinvestment and balance sheet flexibility over immediate shareholder payouts.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen4500.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

More about Medley

Medley, Inc., listed on the Tokyo Stock Exchange under code 4480, operates in the technology-enabled healthcare and human resources services space. The company generates consolidated net sales primarily from digital medical and related platforms, and it targets growth in Japan by expanding its service offerings and customer base across the healthcare ecosystem.

Average Trading Volume: 453,099

Technical Sentiment Signal: Hold

Current Market Cap: Yen70.91B

For detailed information about 4480 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1